Acesso livre
Acesso livre

Pneumologia Pediátrica

M-A | Fatores de risco para um prognóstico ruim em crianças e adolescentes com COVID-19.

22 Out, 2021 | 12:22h

Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis – EClinicalMedicine

Revisão do estado de arte | Diagnóstico e tratamento da displasia broncopulmonar.

21 Out, 2021 | 11:21h

Diagnosis and management of bronchopulmonary dysplasia – The BMJ

 

Comentário no Twitter

 

Estudo randomizado confirma que antibióticos são desnecessários para a maioria das crianças com infecção não complicada de trato respiratório baixo caso não haja suspeita clínica de pneumonia.

27 Set, 2021 | 12:37h

Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial – The Lancet

 

Comentário no Twitter

 

Diretriz Científica da AHA | Distúrbio respiratório do sono e doença cardiovascular em crianças e adolescentes.

27 Set, 2021 | 12:00h

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association – Journal of the American Heart Association

Comunicado de imprensa: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association

Covid: experts do Reino Unido recomendam vacina com única dose para crianças de 12 a 15 anos de idade.

14 Set, 2021 | 14:28h

Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors – BBC

Ver também: Covid-19: Children aged 12-15 should be offered vaccine, say UK’s chief medical officers – The BMJ

A variante Delta da Covid e crianças: relatório mostra que a transmissão em crianças é baixa e somente 2% delas são hospitalizadas.

12 Set, 2021 | 22:16h

The Delta Covid variant and children: transmission in kids is low and only 2% hospitalised, report finds – The Guardian

Relatório: COVID-19 Delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021 – NCIRS

Comunicado de imprensa: COVID-19 Delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021

 

Comentário no Twitter (fio – clique para saber mais)

 

Doença de Kawasaki e síndrome inflamatória multissistêmica em crianças: uma visão geral e comparação.

13 Ago, 2021 | 12:27h

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison – American Family Physician

Conteúdos relacionados:

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

Asma pediátrica: o consenso REGAP.

9 Ago, 2021 | 11:24h

Pediatric asthma: The REGAP consensus – Anales de Pediatría

Diretriz AARC | Tratamento de pacientes pediátricos com oxigênio no contexto de cuidado agudo.

9 Ago, 2021 | 11:23h

AARC Clinical Practice Guideline: Management of Pediatric Patients With Oxygen in the Acute Care Setting – Respiratory Care – American Association for Respiratory Care

Revisão sobre COVID-19: manifestações abdominais em adultos e síndrome inflamatória multissistêmica em crianças.

6 Ago, 2021 | 11:47h

Review of COVID-19, part 1: Abdominal manifestations in adults and multisystem inflammatory syndrome in children – Clinical Imaging

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.